Senior Portfolio Manager

The Senior Portfolio manager—with the support of two reporting portfolio managers —will have responsibility for selecting and guiding pre-clinical research studies with suitable commercial potential across a variety of therapeutic areas including small molecule therapies, biological therapies, biomaterials, biomarkers with therapeutic application and in the area of advanced therapy medicinal products (ATMPs).

Reporting to the Executive Director, and a key member of the Senior Leadership Team, the Senior Portfolio Manager holds primary responsibility for shaping and executing the programme work plan, with a key focus on driving growth, optimizing commercial potential and identifying opportunities to support the ARC Hub vision, mission and strategic direction.

This role will drive the strategic direction of all activities in Trinity, providing leadership across the two portfolio manager roles to ensure rapid and effective responses to ARC academic and industry partner needs, in alignment with the Funding Agencies requirements.

The Senior Portfolio Manager will work collegially across the ARC Hub academic partners to generate collaborative opportunities that will increase the Hub’s impact for its key stakeholders.

The successful candidate will achieve the above objective by:

- Working closely with ARC Executive Director and ARC Academic Director and other senior stakeholders across the 3 partner universities, to forge and implement partnerships and develop an extensive range of activities required to ensure the ARC Hub achieves it’s targets for funding commercilsation projects, to scale engagement with the Innovation eco-system, and deliver for Research Ireland and the commercial entities which will benefit from the programme.

- Manage and direct the team in Trinity, and in other partner institutions and further develop the capability of the ARC Hub by providing leadership to enhance inter-university collaborations, thereby positively promoting the university’s profile and reputation in commercialising research outputs.

- Manage and direct the team in Trinity, and in other partner institutions and further develop the capability of the ARC Hub by providing leadership to enhance inter-university collaborations, thereby positively promoting the university’s profile and reputation in commercialising research outputs.

- Enabling and supporting commercial partnerships linking academic skills, innovation and infrastructure with a wide range of internal researchers, and external clients including industry, public bodies and government entities and entrepreneurs.

- Provide ongoing updates to the senior leadership at the university on the progress of ARC Hub’s strategic goals.

- Identifying and prioritising projects from applications submitted by academics and advising on study design, study protocols, and project specific milestones.

- Supporting the creation of a project dossier, with the input of the HEI Technology Transfer case-managers, Portfolio Managers and the Business and Training Manager, to include an evaluation of the patent landscape, drug tractability, target-disease market potential and other commercially-relevant differentiating factors for the therapy being developed.

- Managing the execution and analysis of the projects and ensuring that the collation and reporting of the data is of a high standard.

- Working closely with the ARC Executive Director in forging relationships with multiple internal and external stakeholders, including members of the Advisory and Executive Committee, academic partners, clinicians, venture capitalists, industry contacts, and CROs/CDMOs.

- Presenting the progress of the projects within the portfolio to colleagues in regular internal research meetings, and to external national/international thought leaders and investors.

- Presenting to the Advisory Committee and Executive Committee on the scientific and commercial progress of projects on an ongoing basis, highlighting key milestones, challenges and opportunities.

- Contributing to the writing of scientific, commercial and outreach material relevant to the activities of the SFI ARC Hub.

- Contributing strategically to the tactical planning and future goals of the ARC Hub through regular interactions with the ARC Executive Director, senior management team, Advisory Committee and Executive Committee.

The ARC Hub for Therapeutics is a collaborative initiative between Trinity College Dublin, University College Dublin, and the Royal College of Surgeons in Ireland, with the aim of guiding academic projects to commercial success on a national scale, in conjunction with other Higher Education Institutions (HEI) in the Republic of Ireland. The ARC Hub is focused on the generation of high-quality spin-outs and licenses in the fields of small molecule therapies, biological therapies, biomaterials, biomarkers with therapeutic potential and in advanced therapy medicinal products (ATMPs). To achieve this objective, the ARC Hub will unite various elements of the Irish biopharma landscape, including venture capitalists, indigenous companies, state agencies, and a network of advisors. This broad alliance will focus on identifying, advising, and guiding academic projects towards commercial success. Additionally, the ARC Hub will focus on developing the translational research skills of academics and postdoctoral researchers. This will involve entrepreneurial training, engagement with external experts, and hands-on experience in taking research to market, thereby nurturing the next generation of entrepreneurial scientists, and fostering a robust and sustainable innovation ecosystem in Ireland.

The ARC HubTherapeutics is supported by the Government of Ireland and the European Union through
the Southern, Eastern and Midland Regional Programme 2021-2027.

TáARCHub for Therapeutics arna chomhchistiú ag Rialtas na hÉireann agus ag an Aontas Eorpachtrí Chlár Réigiúnachan Deiscirt, an Oirthiragus Lár na Tíre 2021-27 de chuid CFRE.